News

New Women’s Health Centers Announced with $20 Million Gift

New Women’s Health Centers Announced with $20 Million Gift

New York-Presbyterian Launches Women's Health Centers with Generous Gift

NewYork-Presbyterian has received a remarkable $20 million donation from entrepreneur and philanthropist Emilia Fazzalari, aimed at creating world-class women's health centers. This significant funding will establish the Emilia Fazzalari Women's Health Center of Excellence and the Emilia Fazzalari Women's Health Program. Collectively known as Fazzalari Women's Health, this initiative intends to revolutionize women's health by prioritizing accessible and integrated care.

Addressing Unique Health Needs

The new women’s health program will provide comprehensive care with a specific emphasis on perimenopause and menopause. These stages of a woman's health journey have historically been overlooked in medical research and treatment. Emilia Fazzalari's vision is to change that by fostering a dedicated program which promises coordinated care, allowing women to take an active role in their health.

Fazzalari stated, "We have rethought and reorganized women's care in a meaningful way. This model brings a new standard to women's health." The program aims to integrate various specialties, thereby offering a holistic approach to women's health services.

A Comprehensive Care Approach

The program will be led by the esteemed Dr. Mary Rosser, who specializes in obstetrics and gynecology. Under her leadership, the Fazzalari Women's Health initiative will focus on addressing the evolving health requirements of women at every stage of life. Through a collaborative approach, care will revolve around a woman’s OB/GYN, supplemented by a team of specialists from NewYork-Presbyterian and Columbia University.

This innovative model replaces the traditional fragmented care experience with a continuous, unified health journey. It centers on empowering women to be informed and proactive regarding their health decisions.

World-Class Facilities and Services

Services will be offered at two premier locations: NewYork-Presbyterian The One in Westchester and a facility located on West 51st Street in Manhattan. The program comprises various services including gynecological, cardiovascular, mental health, neurocognitive, gastrointestinal, and sexual health care, along with nutrition and exercise guidance.

One of the standout aspects of Fazzalari Women's Health is its commitment to providing personalized menopause management plans, addressing both immediate symptoms and long-term health outcomes. Dr. Rosser articulated her gratitude for Fazzalari's invaluable gift, emphasizing the positive impact it will have on women's health.

A Vision for the Future

Dr. Mary D'Alton, another prominent figure in the program, praised Emilia Fazzalari's bold vision for women’s health care, stating, "Her generosity enables us to scale compassionate, personalized care and make it accessible to more women." This initiative marks a significant step toward ensuring women receive the proactive care and support they need during pivotal health transitions.

About NewYork-Presbyterian

NewYork-Presbyterian is recognized among the most comprehensive and integrated academic healthcare systems in the nation, comprising ten hospitals and nearly 200 primary and specialty care facilities across the Greater New York area. This reputable institution is closely affiliated with two distinguished medical schools, enhancing patient access to leading medical expertise and the latest healthcare innovations.

Founded over 250 years ago, NewYork-Presbyterian has a proud legacy of medical advancements, including the invention of the Pap test and the development of groundbreaking procedures in cardiac care.

The dedication of their 50,000 employees and affiliated physicians is centered on providing exceptionally high-quality, compassionate care to individuals from various backgrounds, whether they come from local communities or beyond.

Frequently Asked Questions

What is the purpose of the Emilia Fazzalari Women’s Health Program?

The program aims to deliver coordinated and comprehensive care focused on women's health issues, especially during perimenopause and menopause.

Who is leading the Fazzalari Women’s Health initiative?

Dr. Mary Rosser, a nationally recognized obstetrician-gynecologist, is leading the program.

How many locations will the program serve?

The program will operate at two locations: one in Westchester and another in Manhattan.

What types of services will the Fazzalari Women’s Health program provide?

Services include gynecological care, cardiovascular health, mental health support, and personalized menopause management, among others.

What distinguishes NewYork-Presbyterian’s approach to women’s health?

NewYork-Presbyterian emphasizes a coordinated care model that integrates various specialties to provide holistic support for women's health throughout their lives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 28

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 36

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 168

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 74

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 57

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Best Buddies Challenge Hits $4M For Inclusion

Updated Category News Views 7

A Record-Breaking Year for Best Buddies Everyone loves a good underdog story, and every now and then, you get one that really hits home. The 27th Annual Best Buddies Challenge in Hyannis Port did exactly that, raking in a whopping $4 million and drawing a crowd of nearly 1,000 participants. The event serves as both a fundraiser and a community builder, spotlighting its...

Continue Reading
MSP Recovery Implements Reverse Stock Split for Compliance

Updated Category News Views 239

MSP Recovery Announces a Reverse Stock Split MSP Recovery, Inc. (NASDAQ: MSPR), a leader in Medicare, Medicaid, and secondary payer reimbursement recovery, recently announced a reverse stock split of its Class A common stock at a ratio of 1-for-7. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement. Details of the Stock Split The...

Continue Reading
The Value of a $1000 Investment in Primerica Over 10 Years

Updated Category News Views 127

Understanding Primerica's Growth Over the Last Decade Primerica Inc (NYSE: PRI) has shown remarkable performance, outperforming the market by an annualized rate of 8.02%. This impressive rate results in an average annual return of 19.51% for the investors over the past ten years. As of now, the company has a market valuation of approximately $8.63 billion, indicating...

Continue Reading
Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth

Updated Category News Views 161

Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced an exciting initiative aimed at enhancing cell and gene therapy manufacturing. Eight G-Rex Grants, amounting to nearly $2 million, have been awarded to distinguished recipients within the...

Continue Reading